Indeed, survival signals induced by in vitro stimulation of B-CLL with TNFα, BAFF and CD40L were attenuated by CAL-101 treatment (Herman et al., 2010). The gene discussed is TNFSF13B; the disease is B-cell chronic lymphocytic leukemia.